Rua Bioscience FY22 results to be announced 29 August 2022

FOR PUBLIC RELEASE
NZX Limited
Wellington

26 August 2022


Rua Bioscience FY22 results to be announced on 29 August 2022
Rua Bioscience Limited (NZX:RUA) advises that its results for the 12 months to 30 June 2022 will be
released on Monday 29 August 2022. Management will host a briefing for investors, analysts and
media at:
11am on Tuesday 30 August
Participants can register for the briefing at:
https://s1.c-conf.com/diamondpass/10024687-asfmw4.html
A dial-in number, passcode, and a unique access PIN will be emailed to you as a calendar invitation.
A call transcript will be available in the Investor section of the Rua website several days after the call.

ENDS

For further information, please contact:
Hamish White
Rua Bioscience CFO
0800 RUA BIO
Hamish.white@ruabio.com

For media or investor enquiries, please contact:
Kerry Donovan
Communications Manager
Kerry.donovan@ruabio.com


About Rua
Rua Bioscience (RUA:NZX) is a New Zealand pharmaceutical company that is a pioneer in the
New Zealand medicinal cannabis sector. Established in 2017 to support economic development in
Te Tairāwhiti, Rua holds a licence to operate in the medicinal cannabis sector commercially, has
two commercial-scale facilities and holds a contract with German distributer Nimbus Health to
supply dried flower. Rua’s extensive knowledge of the global market and expertise in: cannabis
plant chemistry and analytics; cultivation and growth optimisation; and processing and
pharmaceutical manufacturing supports its strategy to identify long-term value opportunities.
www.ruabio.com
MARKET ANNOUNCEMENT